日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy

接受联合放射免疫疗法治疗的肝细胞癌患者新抗原的免疫原性

Aparicio, Belén; Silva, Leyre; Ruiz, Marta; Llópiz, Diana; Repáraz, David; Theunissen, Patrick; Tamayo, Ibon; Egea, Josune; Igea, Ana; Smerdou, Cristian; Peñas, Maria; Perpiñá, Cristina; Matilla, Ana; Varela, María; Reig, Maria; de la Torre-Alaez, Manuel; Argemí, Josepmaria; Sangro, Bruno; Hervás-Stubbs, Sandra; Sarobe, Pablo

IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy

肿瘤B细胞来源的IL-10调节弥漫性大B细胞淋巴瘤的微环境和对免疫疗法的反应。

Garcia-Lacarte, Marcos; Grijalba, Sara C; Melchor, Javier; Pascual, Marién; Goñi, Enrique; Clemente-Larramendi, Iñigo; Morales-Sánchez, Sandra; Burrell, María A; Blanco, Oscar; Arnaiz-Leché, Adrián; Berrozpe, Blanca S; Amann, Maria; Klein, Christian; Umaña, Pablo; Canales, Miguel; Martínez-Climent, José Ángel; Lasarte, Juan J; Sarobe, Pablo; Novo, Francisco J; Roa, Sergio

Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting glypican 3 effectively control human hepatocellular carcinoma in mice

经基因工程改造,表达靶向糖蛋白聚糖3的HLA-A2限制性鼠源T细胞受体的人类T细胞,可有效控制小鼠体内的人类肝细胞癌。

Vercher, Enric; Covo-Vergara, Ángela; Conde, Enrique; Hernández-Rueda, Mercedes; Elizalde, Edurne; Mancheño, Uxua; Glez-Vaz, Javier; Tamayo-Uria, Ibon; García-García, Maritza R; Ferrer-Roig, Marta; Marañón-Lopez, Javier; Repáraz, David; Ruiz, Marta; López-Díaz de Cerio, Ascensión; Inogés, Susana; Iñarrairaegui, Mercedes; Lasarte, Juan J; Sangro, Bruno; Sarobe, Pablo; Hervas-Stubbs, Sandra

Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort

在肝癌患者荟萃队列研究中,由非经典开放阅读框编码的微蛋白是肿瘤特异性抗原的主要来源。

Camarena, Marta E; Theunissen, Patrick; Ruiz, Marta; Ruiz-Orera, Jorge; Calvo-Serra, Beatriz; Castelo, Robert; Castro, Carla; Sarobe, Pablo; Fortes, Puri; Perera-Bel, Júlia; Albà, M Mar

Dendritic Cells in Cancer Immunology and Immunotherapy

树突状细胞在癌症免疫学和免疫治疗中的作用

Hato, Laura; Vizcay, Angel; Eguren, Iñaki; Pérez-Gracia, José L; Rodríguez, Javier; Gállego Pérez-Larraya, Jaime; Sarobe, Pablo; Inogés, Susana; Díaz de Cerio, Ascensión López; Santisteban, Marta

Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies

突变衍生的新抗原和非经典抗原在抗癌治疗中的相关性

Aparicio, Belen; Theunissen, Patrick; Hervas-Stubbs, Sandra; Fortes, Puri; Sarobe, Pablo

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

用于预测遗传异质性多发性骨髓瘤免疫治疗结果和免疫逃逸机制的临床前模型

Larrayoz, Marta; Garcia-Barchino, Maria J; Celay, Jon; Etxebeste, Amaia; Jimenez, Maddalen; Perez, Cristina; Ordoñez, Raquel; Cobaleda, Cesar; Botta, Cirino; Fresquet, Vicente; Roa, Sergio; Goicoechea, Ibai; Maia, Catarina; Lasaga, Miren; Chesi, Marta; Bergsagel, P Leif; Larrayoz, Maria J; Calasanz, Maria J; Campos-Sanchez, Elena; Martinez-Cano, Jorge; Panizo, Carlos; Rodriguez-Otero, Paula; Vicent, Silvestre; Roncador, Giovanna; Gonzalez, Patricia; Takahashi, Satoru; Katz, Samuel G; Walensky, Loren D; Ruppert, Shannon M; Lasater, Elisabeth A; Amann, Maria; Lozano, Teresa; Llopiz, Diana; Sarobe, Pablo; Lasarte, Juan J; Planell, Nuria; Gomez-Cabrero, David; Kudryashova, Olga; Kurilovich, Anna; Revuelta, Maria V; Cerchietti, Leandro; Agirre, Xabier; San Miguel, Jesus; Paiva, Bruno; Prosper, Felipe; Martinez-Climent, Jose A

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

更正:肽疫苗诱导的抗体增强了对SARS-CoV-2 Omicron变异株的交叉识别

Aparicio, Belén; Ruiz, Marta; Casares, Noelia; Silva, Leyre; Egea, Josune; Pérez, Patricia; Albericio, Guillermo; Esteban, Mariano; García-Arriaza, Juan; Lasarte, Juan J; Sarobe, Pablo

Improvement in RAID questionnaire results in patients with rheumatoid arthritis treated with advanced therapies

接受先进疗法治疗的类风湿性关节炎患者的 RAID 问卷调查结果有所改善

Rodríguez Esquíroz, Andrea; Arrondo Velasco, Amaya; Egüés Lugea, Amaia; Sarobe Carricas, Maite

Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one

对第一种抗CGRP单克隆抗体无反应的偏头痛患者,换用第二种抗体则可获益。

Fresán-Restituto, D; Lacalle-Fabo, E; Martín-Bujanda, M; Sarobe-Carricas, M T